How deaths can help clinicians and policy‐makers understand the risks of novel psychoactive substances-Reference-Cited by-同舟云学术

How deaths can help clinicians and policy‐makers understand the risks of novel psychoactive substances

Published:2020-01-14 Issue:3 Volume:86 Page:482-498
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Corkery John Martin¹^ORCID,Schifano Fabrizio¹,Martinotti Giovanni¹

Affiliation:

1. Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences University of Hertfordshire Hatfield Hertfordshire UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14183

Reference54 articles.

1. CHAPTER 8. Novel Psychoactive Substances (NPS) and Recent Scenarios: Epidemiological, Anthropological and Clinical Pharmacological Issues

2. Acute risk of drug-related death among newly released prisoners in England and Wales

3. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England

4. Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand

5. Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances (‘legal highs’) in New Zealand

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring healthcare professional’s engagements and experiences towards people who use new psychoactive substances in different addiction and mental healthcare services;Advances in Dual Diagnosis;2024-08-26

2. Clinical manifestations and analytical reports for MDPHP acute intoxication cases;Journal of Pharmaceutical and Biomedical Analysis;2024-04

3. Understanding methiopropamine, a new psychoactive substance: an in-depth review on its chemistry, pharmacology and implications to human health;International Journal of Legal Medicine;2024-03-01

4. Experience and views of healthcare professionals towards people who use new psychoactive substances: Evidence from statutory, non‐statutory, and private mental health and addiction healthcare services;Human Psychopharmacology: Clinical and Experimental;2023-10-16

5. Flualprazolam and flubromazolam: Blood concentrations and prevalence of two novel psychoactive substances in forensic case work in Ontario, Canada;Journal of Analytical Toxicology;2023-08-18